Movano Inc. (NASDAQ:MOVE – Get Free Report) was the target of a significant decline in short interest in November. As of November 15th, there was short interest totalling 32,300 shares, a decline of 74.8% from the October 31st total of 128,300 shares. Currently, 0.6% of the shares of the stock are short sold. Based on an average trading volume of 25,600 shares, the short-interest ratio is currently 1.3 days.
Analyst Ratings Changes
Separately, Benchmark reiterated a “speculative buy” rating and set a $30.00 target price on shares of Movano in a research report on Wednesday, September 4th.
Check Out Our Latest Research Report on MOVE
Institutional Investors Weigh In On Movano
Movano Trading Up 49.7 %
Shares of NASDAQ:MOVE traded up $1.79 during midday trading on Wednesday, reaching $5.39. 705,717 shares of the company were exchanged, compared to its average volume of 19,930. The business’s fifty day moving average is $4.52 and its two-hundred day moving average is $5.12. Movano has a one year low of $2.80 and a one year high of $14.40. The stock has a market cap of $35.74 million, a PE ratio of -1.04 and a beta of 0.18.
Movano Company Profile
Movano Inc engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
Featured Stories
- Five stocks we like better than Movano
- How to invest in marijuana stocks in 7 stepsĀ
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Are the FAANG Stocks and Are They Good Investments?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is the FTSE 100 index?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.